OCLN and pulmonary edema: Further, Solnatide (AP301), a specific direct activator of ENaC, was able to restore alveolar epithelial barrier function, including occludin expression, and reduce pulmonary edema in a rat model of high altitude pulmonary edema, showing the therapeutic potential of ENaC regulation37.